Minghui Pharmaceutical (Hangzhou) Ltd
Registry sponsor category
Industry
- Other names
- Minghui Pharmaceutical (Hangzhou) Ltd
- Company name
- Minghui Pharmaceutical (Hangzhou) Ltd
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (20)
- A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo
- A Study of MHB009C in Patients With Advanced Solid Tumors
- A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
- A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
- A Study of MHB036C for Advanced Solid Tumor
- A Study of MHB039A for Advanced Solid Tumor
- A Study of MHB042C in Patients With Advanced Solid Tumors
- A Study of MHB046C Injection in Patients With Advanced Solid Tumors
- A Study of MHB048C in Patients With Advanced Solid Tumors
- A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
- A Study of MHB118C Injection in Patients With Advanced Solid Tumors
- MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis
- MHB018A Treatment in Patients With Active Thyroid Eye Disease
- MHB018A Treatment in Patients With Chronic Thyroid Eye Disease
- Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease
- Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
- Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo
- Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study
- Treatment of Chronic Thyroid Eye Disease With MHB018A